Aoxing Pharmaceutical Co., Inc. (AXN) Reports Q1 Loss of $0.02
Tweet
Share
E-mailGet Alerts AXN Hot Sheet
Join SI Premium – FREE
Aoxing Pharmaceutical Co., Inc. (NYSE: AXN) reported Q1 EPS of ($0.02), versus ($0.01) reported last year. Revenue for the quarter came in at $1.53 million, versus $1.74 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
- C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance
- John Wiley & Sons, Inc. (WLY) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
